Chris Rundfeldt,Rita Dost,Wolfgang Loscher,Andrea Tipold,Klaus Unverferth,Hans-Joachim Lankau
申请号：
US14542888
公开号：
US09469611B2
申请日:
2014.11.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
